By James Draper For Mailonline
PUBLISHED: 18:00, 4 January 2017 | UPDATED: 18:00, 4 January 2017
Researchers at the National Institutes of Health have identified how the neurological conditions develop differently between patients
The finding could revolutionise medical treatment and even lead to new drugs
About 850,000 people are living with Alzheimer’s in the UK, a figure expected to to rise to a million by 2025
The treatment of Alzheimer’s Disease could be revolutionised after a breakthrough discovery by US scientists.
Researchers at Maryland’s National Institutes of Health have identified how the neurological condition develops differently between patients – a move which offers fresh scope for better, more-targeted drugs.
The findings, published in medical journal Nature on Wednesday, shed fresh light on the toxic chemicals behind dementia and offers renewed hope of a remedy.
Game-changer: The latest findings will further develop the way medicine can treat dementia
One of the main causes of dementia is the clumping together of a protein known as amyloid beta.
It has been suggested different formations of these fine fibres, or fibrils, may be linked with different forms of Alzheimer’s.
So the researchers, lead by Dr Robert Tycko, analysed 37 brain tissue samples from 18 individuals who had died from either typical Alzheimer’s or two unusual subtypes of the disease.